Comunicazioni Poster Giovani Ricercatori 2026

Spring Meeting Giovani Ricercatori 
SID-SIGG-SIIA-SIMI-SIPREC-SISA 2026


Presentazione dei poster: 4+3 min
Poster: layout verticale dimensione massima 70x100 cm
I poster devono essere stampati e appesi negli spazi indicati

Domenica 19 Aprile 2026

19.15-20.30

Sessione Poster 1 - MASLD, NAFLD and hepatometabolic liver disease
Moderatori: Marta Biolo (Padova); Alessandro Gezzi (Ancona)

01 - Gut-Derived Endotoxemia and Dyslipidemia as Predictors of Sarcopenia in Older Patients with metabolic dysfunction–associated steatotic liver disease (MASLD)
• Marta Peccarisi
02 - Lipoprotein(a) Levels Across Histological Severity in Metabolic Dysfunction–Associated Steatotic Liver Disease
• Gaetano Leo
03 - Evaluating steroid profiles through sexual dimorphism to define metabolic phenotypes and identify advanced fibrosis in patients with MASLD
• Mirko Parasiliti-Caprino
04 - Age-Related Differences in Lipid Profile and Insulin Resistance Markers in patients with metabolic dysfunction–associated steatotic liver disease (MASLD)
• Andrea Bagnato
05 - Dyslipidemia in patients with primary biliary cholangitis (PBC) is less atherogenic than in patients with primary polygenic hypercholesterolemia
• Michele Tafuro

19.15-20.30

Sessione Poster 2 - Hypertension, vascular damage and secondary hypertension 
Moderatori: Francesco Giglioni (Perugia); Alessia Cipollone (Chieti)

01 - The Sinuses of Valsalva/Ascending Aorta Diameter Ratio as a Marker of Subclinical Cardiovascular Damage in Hypertension
• Simona Persia
02 - Small-RNA characterization of circulating extracellular vesicles from patients with adrenal-producing adenomas
• Gabriele Leone
03 - Prevalence and predictors of intolerance to Calcium Channel Blocker in an Italian hypertensive outpatient cohort
• Lara Ponsa
04 - Predictors of Treatment Response to Mineralocorticoid Receptor Antagonist Therapy in Primary Aldosteronism: data from the SPAIN-ALDO Registry
• Jessica Goi
05 - Renin-to-aldosterone ratio is mechanistically associated with ambulatory blood pressure levels and control in treated hypertensive patients with overweight or obesity
• Sara Moriglia
06 - Renal denervation in resistant hypertension: short-term blood pressure effects and the role of potential predictive markers of response
• Giuseppe Simone Falcone
07 - Sex-specific pharmaco-epidemiology in hypertensive patients
• Vanessa De Santis
08 - Atherosclerotic renovascular hypertension: when CT angiography underestimates disease severity
• Annalisa D’Alfonso

19.15-20.30

Sessione Poster 3 - Lipid disorders, lipoproteins and lipid-lowering therapy
Moderatori: Giovanna Gallo (Roma); Francesco Alfano (Firenze)


01 - ELASTIC (Effect of new Lipid-lowering therApies on arterial STructural and funCtIonal properties) study: no significant effects on arterial structural and functional properties of PCSK9 inhibitory monoclonal antibodies
• Marco Bellomare
02 - Real-world experience with lipoprotein apheresis for elevated Lipoprotein(a): insights from the Padua cohort
• Camilla Portinari
03 - Lipoprotein(a) and Residual Cardiovascular Risk: Evidence from a Real-World Lipid Clinic Cohort
• Ilaria Rossi
04 - Bempedoic acid: real-world data and sex-specific analysis from an Italian cohort
• Elisa Acitelli
05 -Achievement of LDL cholesterol targets in HIV-positive patients
• Michela Algeri
06 - Clinical management and outcomes of bempedoic in type 2 Diabetes: a retrospective cohort study
• Andrea Sablone
07 - Efficacia e sicurezza dell’acido bempedoico nella pratica clinica: analisi real world e predittori di risposta
• Simone Mattivi
08 - Efficacy of dual therapy (evinacumab and lomitapide) in  a HoFH patient
• Iliana Iemmolo

19.15-20.30

Sessione Poster 4 - Atherosclerosis, vascular biology and inflammation
Moderatori: Lorenzo Da Dalt (Milano); Elena Levati (Roma)

01 -Plasma proteomics to differentiate FH patients from hypercholesterolaemic patients
• Amirbahman Zeynali
02 - Effects of gliflozins on Lecithin:Cholesterol Acyltransferase
• Chiara Comi
03 - Arterial functional and structural effects of PCSK9 Inhibitors: a comparison between antibody and small interfering RNA
• Martina Zampoleri
04 - The role of Runt-Related Transcription Factor1 (Runx1) in the phenotypic switch of Vascular Smooth Muscle Cells during atherosclerosis
• Elisa Nespoli
05 - Effects of bempedoic acid on arterial structural and functional parameters
• Daniele Pozzoli
06 - Postprandial VLDL and endothelial inflammatory activation: in vitro studies
• Davide Barbarossa
07 - VEGFA/VEGFR2 axis regulate crosstalk between senescent vascular smooth muscle cells and intraplaque neovessels in atherosclerosis
• Clara Rossi
08 - Colonic (poly)phenol metabolites as promising tools to control inflammation and prevent cardiovascular disease
• Paola Bonicco

19.15-20.30

Sessione Poster 5
Moderatori: Valeria Visco (SIIA) & Alfredo Caturano (SID)

01 - Sex- and Age-Specific Prognostic Value of Serum Uric Acid for Cardiovascular Events: Insights from the URRAH Study
• Guendalina Vizza
02 - Increased plasma C-reactive protein levels predicts unfavourable cardiovascular prognosis in subjects at increased ASCVD risk and impaired kidney function: longitudinal results from the IMPROVE study
• Filippo Figorilli
03 - Total-cholesterol-to-triglycerides ratio as a predictor of 30-day mortality and cardiovascular complication in patients with sepsis: a retrospective cohort study
• Francesco Maria Di Luca
04 - PRedictive Evaluation of Cardiovascular rIsk Scores for subclinical damage in Early inflammatory joint disease: the PRECISE study
• Arianna Toscano
05 - Lipoprotein(a) does not correlate with hypertensive mediated organ damage and subsequent cardiovascular events in a primary prevention cohort
• Beatrice Invernici
06 - High cardiovascular risk and poor risk factor control in patients living with COPD: real-world evidence
• Simone Pugnaloni
07 - Vitamin D levels in a population of healthy subjects and its association with metabolic derangement and cardiac and carotid target organ damage
• Isabella Soliman

18.00-19.00

Sessione Poster 6 - Diabetes, obesity, nutrition and endocrine metabolism 
Moderatori: Simone Bini (Roma); Ilaria Fucile (Napoli)

01 - Dietary carbohydrate restriction affects hepatic glucose production and intestinal glucose absorption independently of body weight loss
• Noemi Cimbalo
02 - Mediterranean diet effects on vascular health and serum levels of adipokines and ceramides
• Stefania Scaglione
03 - Distinct interplay between β-cell function and insulin sensitivity in latent autoimmune diabetes in adults and type 2 diabetes
• Rocco Amendolara
04 - Real-world efficacy and safety of SGLT2-inhibitors in an elderly population
• Soheil Houshan
05 - Management of polypharmacoterapy in hypercholesterolemic patients treated with bempedoic acid: a monocentric, real-world observational study
• Artenca Shehu
06 - Free fatty acids impair steroidogenesis and promote apoptosis in leydig cells: A new link between metabolic dysfunction and hypogonadism
• Celeste Lauriola
07 - Glycemic levels correlate with inflammation in burn patients
• Maria Luisa D’Onghia
08 - Citrus waste-derived flavonoids as potential agents for diabetes and obesity management
• Rosario Mare 
09 - Reproducibility of Continuous Glucose Monitoring-derived postprandial glucose features and their potential use as predictors of glycemic control in type 2 diabetes
• Annalisa Giosuè

18.00-19.00

Sessione Poster 7 - Heart failure, arrhythmias and cardiac rehabilitation
Moderatori: Giulio Francesco Romiti (Roma); Sara Coluzzi (Pescara)

01 - SGLT2 inhibition ameliorates physical function in frail older adults with HFpEF and diabetes
• Marco Savino
02 - Age-Related Enhancement of COX-1–Mediated Thromboxane Production in Patients with Atrial Fibrillation
• Emanuele Valeriani
03 - Heart failure with preserved ejection fraction in hospitalized older adults: guidelines and diagnostic uncertainties
• Clara Musarò
04 - Eligibility for icosapent ethyl in patients undergoing cardiac rehabilitation: a real-world cohort study
• Sara D’Alesio
05 - SGLT2-inhibitors and GLP1-receptor agonists decrease Plasma NT-proBNP in patients with type 2 diabetes mellitus and heart stress: a longitudinal multicenter real-life study
• Michela Cecchini
06 - Pharmacological rhythm control strategy and outcomes in very elderly atrial fibrillation patients: an analysis of the nationwide Italian START registry
• Danilo Menichelli
07 - Lipoprotein(a) plasma levels and coagulation biomarkers: results from a comprehensive laboratory assessment in an angiographically-controlled cardiovascular cohort
• Nicola Osti
08 - High prevalence of advanced cardiovascular-kidney-metabolic syndrome in cardiac rehabilitation patients and therapeutic implications: a single-day observational study
• Francesca Monego

18.00-19.00

Sessione Poster 8 - Aging, frailty and geriatric medicine
Moderatori: Antonio Michele Bussu (Carbonia); Elena Olmastroni (Milano)

01 - Does the use of benzodiazepine influence the effectiveness of lifestyle intervention? Secondary analysis from the Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies (SPRINTT) trial
• Elena Levati
02 - Sex-Specific Prognostic Performance of the CALLY Index in Hospitalized Older Adults
• Alessandro Perencin
03 - Prognostic Value of the C-reactive protein-triglyceride glucose index in Older Hospitalized Patients
• Carlotta De Nuntiis
04 - Identification of potential circulating biomarkers of frailty in hospitalized older adults
• Laura Andreea Ceparano
05 - Serum Creatinine variations in hip fracture patients: is muscle mass loss the culprit?
• Barbara Fioretti
06 - Predictors of mortality in hypertensive older patients with obstructive sleep apnea: the role of intermittent hypoxia
• Alessandro Gezzi
07 - Phenoage is associated with in-hospital mortality in non-critical patients
• Alessia Riccio